We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00861627
Brief Title: Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation

First Submitted : March 12, 2009
First Submitted that Met QC Criteria : March 12, 2009
First Posted : March 13, 2009 (Estimate)

Last Update Submitted : December 1, 2015
Last Update Submitted that Met QC Criteria : December 1, 2015
Last Update Posted : December 2, 2015 (Estimate)